These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3382303)

  • 21. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival prediction of patients with advanced cancer: the predictive accuracy of the model based on biological markers.
    Kikuchi N; Ohmori K; Kuriyama S; Shimada A; Nakaho T; Yamamuro M; Tsuji I
    J Pain Symptom Manage; 2007 Dec; 34(6):600-6. PubMed ID: 17629667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing hospice and nonhospice patient survival among patients who die within a three-year window.
    Connor SR; Pyenson B; Fitch K; Spence C; Iwasaki K
    J Pain Symptom Manage; 2007 Mar; 33(3):238-46. PubMed ID: 17349493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human tetranectin: methodological and clinical studies.
    Høgdall CK
    APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer.
    Kanemitsu Y; Kato T; Hirai T; Yasui K
    Br J Surg; 2004 Jan; 91(1):112-20. PubMed ID: 14716804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
    Mauer ME; Taphoorn MJ; Bottomley A; Coens C; Efficace F; Sanson M; Brandes AA; van der Rijt CC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ;
    J Clin Oncol; 2007 Dec; 25(36):5731-7. PubMed ID: 18089867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
    Woodard TD; Oplatek A; Petruzzelli GJ
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The terminal cancer syndrome.
    Schonwetter RS; Teasdale TA; Storey P
    Arch Intern Med; 1989 Apr; 149(4):965-6. PubMed ID: 2705852
    [No Abstract]   [Full Text] [Related]  

  • 36. Workshop for the evaluation of survival trends for cancer patients.
    Watanabe S; Oshima A; Fujimoto I; Wada T; Maruyama K
    Jpn J Clin Oncol; 1989 Jun; 19(2):178-80. PubMed ID: 2733174
    [No Abstract]   [Full Text] [Related]  

  • 37. Predicting survival in terminal cancer.
    Byar DP; Mantel N; Hankey BF
    Br Med J; 1973 Mar; 1(5853):611. PubMed ID: 4694413
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of a web-based prognostic calculator on prognostic confidence in outpatient palliative care.
    Hui D; Maxwell JP; de la Rosa A; Jennings K; Vidal M; Reddy A; Azhar A; Dev R; Tanco K; Heung Y; Delgado-Guay M; Zhukovsky D; Arthur J; Reddy S; Yennu S; Ontai A; Bruera E
    Support Care Cancer; 2024 Oct; 32(11):714. PubMed ID: 39377783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis.
    Taniguchi J; Mikura S; da Silva Lopes K
    Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy.
    Johnson PC; Dhawale T; Newcomb RA; Amonoo HL; Lavoie MW; Vaughn D; Karpinski K; El-Jawahri A
    Blood Adv; 2023 Jul; 7(14):3541-3550. PubMed ID: 36995091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.